The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Uveitis: A Potentially Blinding Disease
Abstract
Uveitis (intraocular inflammation) is a potentially blinding group of, probably autoimmune, conditions predominantly occurring in the working age group. Although the aetiology is unknown in most cases, many patients have an associated underlying systemic disease. Central vision loss, in the form of cystoid macular oedema, is the commonest type of visual impairment. Although historical incidence and prevalence data exists, little is known about the degree of vision loss experienced, and the social and financial consequences of having temporary or permanent visual impairment in this age group. The literature is also full of uncontrolled studies and case reports of different modalities of drug therapy for uveitis. This article attempts to raise the awareness of uveitis as an important sight-threatening group of conditions by highlighting the paucity of evidence-based data on epidemiological, quality of life, socioeconomic, and therapeutic aspects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Development of the 25-list-item National Eye Institute Visual Function Questionnaire
Mangione, C. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.7.1050 · Cited by 2,230
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Prevalence of age-related maculopathy
Klein, R., Klein, B. E. K., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31871-8 · Cited by 1,845
ANKYLOSING SPONDYLITIS AND HL-A 27
Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C. O., & Sturrock, R. D. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91360-3 · Cited by 1,836
Thylefors, B., Négrel, A. D., Pararajasegaram, R., & Dadzie, K. Y. (1995) · Europe PMC (PubMed Central) · Cited by 1,292
Leibowitz, H. M., Krueger, D. E., Maunder, L. R., Milton, R. C., KINI, M. M., Kahn, H. A., Nickerson, R. J., Pool, J., Colton, T., Ganley, J. P., et al. (1980) · PubMed · Cited by 1,250
Jabs, D. A., Rosenbaum, J. T., Foster, C. S., Holland, G. N., Jaffe, G. J., Louie, J. S., Nussenblatt, R. B., Stiehm, E. R., Tessler, H., Van Gelder, R. N., et al. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00659-0 · Cited by 995
The VF-14: An Index of Functional Impairment in Patients With Cataract
Steinberg, E. P. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090170074026 · Cited by 960
Causes and frequency of blindness in patients with intraocular inflammatory disease.
Rothova, A., Suttorp-van Schulten, M. S., Frits Treffers, W., & Kijlstra, A. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.4.332 · Cited by 904
Klaver, C. C. W. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.5.653 · Cited by 881
The Prevalence of Age-related Maculopathy in the Rotterdam Study
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31034-2 · Cited by 815
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807
Bloch-Michel, E., & Nussenblatt, R. B. (1987) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74235-7 · Cited by 729
A Controlled Trial of Azathioprine in Behçet's Syndrome
Yazici, H., Pazarli, H., Barnes, C. G., Tüzün, Y., Özyazgan, Y., Silman, A., Serdaroğlu, S., Oğuz, V., Yurdakul, S., Lovatt, G. E., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002013220501 · Cited by 647
The possible impact of uveitis in blindness: a literature survey.
Suttorp-Schulten, M. S., & Rothova, A. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.9.844 · Cited by 616
Blindness and Visual Impairment in an American Urban Population: The Baltimore Eye Survey
Tielsch, J. M. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070040138048 · Cited by 608
Uveitis: Fundamentals and Clinical Practice
(1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070060042035 · Cited by 521
The natural history of uveitis
Nussenblatt, R. B. (1990) · International Ophthalmology · doi:10.1007/bf00163549 · Cited by 514
Causes of Uveitis in the General Practice of Ophthalmology
McCANNEL, C. A., THE UCLA COMMUNITY-BASED UVEITIS STUDY GROUP, HOLLAND, G. N., HELM, C. J., CORNELL, P. J., WINSTON, J. V., & RIMMER, T. G. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70532-x · Cited by 491
Tumor necrosis factors: developments during the last decade.
Aggarwal, B. B., & Natarajan, K. (1996) · PubMed · Cited by 469
Referral Patterns of Uveitis in a Tertiary Eye Care Center
Rodriguez, A. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100130585016 · Cited by 439
Henderly, D. E., Genstler, A. J., Smith, R. E., et al. (1987) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74217-5 · Cited by 390
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation
Streilein, J. W. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102574 · Cited by 367
Javitt, J. C., Aiello, L. P., Chiang, Y., Ferris, F. L., Canner, J. K., & Greenfield, S. (1994) · Diabetes Care · doi:10.2337/diacare.17.8.909 · Cited by 364
Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis
Young, S., Larkin, G., Branley, M., & Lightman, S. (2001) · Clinical & Experimental Ophthalmology · doi:10.1046/j.1442-9071.2001.00360.x · Cited by 352
Chang, J. H.-M., & Wakefield, D. (2002) · Ocular Immunology and Inflammation · doi:10.1076/ocii.10.4.263.15592 · Cited by 349
Rothova, A., Buitenhuis, H. J., Meenken, C., Brinkman, C. J., Linssen, A., Alberts, C., Luyendijk, L., & Kijlstra, A. (1992) · British Journal of Ophthalmology · doi:10.1136/bjo.76.3.137 · Cited by 324
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
Bonifazi, F., de Vivo, A., Rosti, G., Guilhot, F., Guilhot, J., Trabacchi, E., Hehlmann, R., Hochhaus, A., Shepherd, P. C. A., Steegmann, J. L., et al. (2001) · Blood · doi:10.1182/blood.v98.10.3074 · Cited by 321
Bartolucci, P. (2002) · Rheumatology · doi:10.1093/rheumatology/41.10.1126 · Cited by 304
Etanercept therapy in children with treatment-resistant uveitis
Reiff, A., Takei, S., Sadeghi, S., Stout, A., Shaham, B., Bernstein, B., Gallagher, K., & Stout, T. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1411::aid-art235>3.0.co;2-o · Cited by 298
Chronic Severe Uveitis: Etiology and Visual Outcome in 927 Patients from a Single Center
BODAGHI, B., CASSOUX, N., WECHSLER, B., HANNOUCHE, D., FARDEAU, C., PAPO, T., HUONG, D. L. T., PIETTE, J.-C., & LEHOANG, P. (2001) · Medicine · doi:10.1097/00005792-200107000-00005 · Cited by 297
Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis
Santos Lacomba, M., Marcos Martín, C., Gallardo Galera, J. M., Gómez Vidal, M. A., Collantes Estévez, E., Ramírez Chamond, R., & Omar, M. M. (2001) · Ophthalmic Research · doi:10.1159/000055677 · Cited by 296
Epidemiology of Uveitis: Incidence and Prevalence in a Small Urban Community
DARRELL, R. W. (1962) · Archives of Ophthalmology · doi:10.1001/archopht.1962.00960030506014 · Cited by 294
Kotter, I. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.423 · Cited by 274
Alpsoy, E., Durusoy, C., Yilmaz, E., Ozgurel, Y., Ermis, O., Yazar, S., & Basaran, E. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.4.467 · Cited by 273
Nussenblatt, R. B., Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7462 · Cited by 259
World blindness: a 21st century perspective
Taylor, H. R. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.3.261 · Cited by 254
Reidy, A., Minassian, D. C., Vafidis, G., Joseph, J., Farrow, S., Wu, J., Desai, P., & Connolly, A. (1998) · BMJ · doi:10.1136/bmj.316.7145.1643 · Cited by 250
Methotrexate therapy for chronic noninfectious uveitis
Samson, C. M., Waheed, N., Baltatzis, S., & Foster, C. S. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00576-0 · Cited by 250
Visual Function Assessment Questionnaires
Massof, R. W., & Rubin, G. S. (2001) · Survey of Ophthalmology · doi:10.1016/s0039-6257(01)00194-1 · Cited by 247
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis
Jaffe, G. J., Ben-nun, J., Guo, H., Dunn, J. P., & Ashton, P. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00466-8 · Cited by 234
Prognostic Factors in the Uveitis of Juvenile Rheumatoid Arthritis
Wolf, M. D., Lichter, P. R., & Ragsdale, C. G. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)80007-6 · Cited by 205
Cost-Effectiveness of Strategies for Detecting Diabetic Retinopathy
Dasbach, E. J., Fryback, D. G., Newcomb, P. A., Klein, R., & Klein, B. E. K. (1991) · Medical Care · doi:10.1097/00005650-199101000-00003 · Cited by 184
Blindness and Visual Impairment in an American Urban Population-Reply
Tielsch, J. M. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070120023007 · Cited by 182
Development of a questionnaire for measurement of vision-related quality of life
Frost, N. A., Sparrow, J. M., Durant, J. S., Donovan, J. L., Peters, T. J., & Brookes, S. T. (1998) · Ophthalmic Epidemiology · doi:10.1076/opep.5.4.185.4191 · Cited by 166
Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.
Jaffe, G. J., Yang, C., Guo, H., Denny, J. P., Lima, C., & Ashton, P. (2000) · PubMed · Cited by 164
El-Shabrawi, Y., & Hermann, J. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01292-7 · Cited by 164
Nussenblatt, R. B., Palestine, A. G., Chao Chan, C., Stevens, G., Mellow, S. D., & Green, S. B. (1991) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)76692-9 · Cited by 162
Larkin, G. B., & Lightman, S. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90078-7 · Cited by 152
Nussenblatt, R. B., Gery, I., Weiner, H. L., et al. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71070-0 · Cited by 152
Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital
Smit, R. L. M. J., Baarsma, G. S., & de Vries, J. (1993) · International Ophthalmology · doi:10.1007/bf00942778 · Cited by 145
Visual Functioning and General Health Status in Patients With Uveitis
Schiffman, R. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.6.841 · Cited by 144
Herpes simplex virus type 2 as a cause of acute retinal necrosis syndrome in young patients
Gelder, R. N. V., Willig, J. L., Holland, G. N., et al. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00556-5 · Cited by 138
Chronic Hepatitis C Virus Infection
Flamm, S. L. (2003) · JAMA · doi:10.1001/jama.289.18.2413 · Cited by 133
Campath-1H therapy in refractory ocular inflammatory disease
Dick, A. D. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.1.107 · Cited by 128
Jobanputra, P., Barton, P., Bryan, S., & Burls, A. (2002) · Health Technology Assessment · doi:10.3310/hta6210 · Cited by 126
Buch, H., Vinding, T., la Cour, M., & Nielsen, N. V. (2001) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2001.790503.x · Cited by 121
A Clinical Trial of FK506 in Refractory Uveitis
Mochizuki, M., Masuda, K., Sakane, T., Ito, K., Kogure, M., Sugino, N., Usui, M., Mizushima, Y., Ohno, S., 稲葉, 午., et al. (1993) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)73645-1 · Cited by 119
Endogenous Uveitis: An Analysis of 1,417 Cases
Pivetti‐Pezzi, P., Accorinti, M., Cava, M. L., et al. (2010) · Ophthalmologica · doi:10.1159/000310715 · Cited by 119
Rescue therapy with mycophenolate mofetil in refractory uveitis
Kilmartin, D. J., Forrester, J. V., & Dick, A. D. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79515-5 · Cited by 119
PERKINS, E. S., & Folk, J. C. (2010) · Ophthalmologica · doi:10.1159/000309382 · Cited by 108
Epidemiology of uveitis in Switzerland
Tran, V. T., Auer, C., Guex‐Crosier, Y., et al. (1994) · Ocular Immunology and Inflammation · doi:10.3109/09273949409057073 · Cited by 103
What is the cost of blindness?
Meads, C., & Hyde, C. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.10.1201 · Cited by 100
Self-citationForrester, J. V. (1991) · The Lancet · doi:10.1016/0140-6736(91)92309-p · Cited by 100
Federal Budgetary Costs of Blindness
Chiang, Y.-P., Bassi, L. J., & Javitt, J. C. (1992) · Milbank Quarterly · doi:10.2307/3350062 · Cited by 98
Sugi-Ikai, N., Nakazawa, M., Nakamura, S., Ohno, S., & Minami, M. (1998) · PubMed · Cited by 97
FK506 Treatment of Noninfectious Uveitis
Ishioka, M., Ohno, S., Nakamura, S., Isobe, K., Watanabe, N., Ishigatsubo, Y., & Tanaka, S. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)72551-6 · Cited by 93
Regular review: Management of chronic uveitis
McCluskey, P., Towler, H. M., & Lightman, S. (2000) · BMJ · doi:10.1136/bmj.320.7234.555 · Cited by 87
Unrecognised and unregistered visual impairment.
Robinson, R., Deutsch, J., JONES, H., Youngson‐Reilly, S., Hamlin, D., Dhurjon, L., & Fielder, A. R. (1994) · British Journal of Ophthalmology · doi:10.1136/bjo.78.10.736 · Cited by 82
Recent trends in the registration of blindness and partial sight in Leicestershire.
Thompson, J. R., Du, L., & Rosenthal, A. R. (1989) · British Journal of Ophthalmology · doi:10.1136/bjo.73.2.95 · Cited by 80
Cyclosporin in the treatment of severe chronic idiopathic uveitis.
de Vries, J., Baarsma, G. S., Zaal, M. J. W., Boen-Tan, T. N., Rothová, A., Buitenhuis, H. J., Schweitzer, C. M., de Keizer, R. J. W., & Kijlstra, A. (1990) · British Journal of Ophthalmology · doi:10.1136/bjo.74.6.344 · Cited by 76
Vision loss: a public health problem?
SAADDINE, J. B., Narayan, K. M. V., & Vinicor, F. (2003) · Ophthalmology · doi:10.1016/s0161-6420(02)01839-0 · Cited by 74
INCIDENCE OF UVEITIS IN NORTHERN FINLAND
MIETTINEN, R. (1977) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1977.tb01306.x · Cited by 71
Efficacy and safety of systemic recombinant interferon‐alpha in Behcet's disease
Georgiou, Monastirli, Pasmatzi, Gartaganis, Goerz, & Tsambaos (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00159.x · Cited by 63
Dick, A. D., Cheng, Y. F., Liversidge, J., & Forrester, J. V. (1994) · PubMed Central · Cited by 60
The epidemiology and genetics of endogenous uveitis: a review
Baarsma, G. S. (1992) · Current Eye Research · doi:10.3109/02713689208999505 · Cited by 60
Causes of blindness in The Netherlands
Doesschate, J. T. (1982) · Documenta Ophthalmologica · doi:10.1007/bf01675857 · Cited by 57
Immune Mechanisms of Uveitis: Insights Into Disease Pathogenesis and Treatment
Dick, A. D. (2000) · International Ophthalmology Clinics · doi:10.1097/00004397-200004000-00003 · Cited by 55
Direct costs of blindness in Australia
Wright, S. E., Keeffe, J. E., & Thies, L. S. (2000) · Clinical and Experimental Ophthalmology · doi:10.1046/j.1442-9071.2000.00296.x · Cited by 53
Correlation between visual function and visual ability in patients with uveitis
Gardiner, A. M., Armstrong, R. A., Dunne, M. C. M., & Murray, P. I. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.9.993 · Cited by 48
Self-citationBiodegradable scleral implant for intravitreal controlled release of fluconazole
Miyamoto, H., Ogura, Y., Hashizoe, M., Kunou, N., Honda, Y., & Ikada, Y. (1997) · Current Eye Research · doi:10.1076/ceyr.16.9.930.5042 · Cited by 47
Blindness from uveitis in a hospital population in Sierra Leone.
Ronday, M. J., Stilma, J. S., Barbe, R. F., Kijlstra, A., & Rothová, A. (1994) · British Journal of Ophthalmology · doi:10.1136/bjo.78.9.690 · Cited by 39
Behcet's syndrome: a multidisciplinary approach to clinical care
Whallett, A., Thurairajan, G., Hamburger, J., Palmer, R. G., & Murray, P. I. (1999) · QJM · doi:10.1093/qjmed/92.12.727 · Cited by 36
Self-citationKrumpaszky, H. G., & Klauß, V. (1992) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/s-2008-1045729 · Cited by 35
Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
Dick, A. D., Siepmann, K., Dees, C., Duncan, L., Broderick, C. A., Liversidge, J., & Forrester, J. V. (1999) · PubMed · Cited by 34
Cited by
The role of infections in autoimmune disease
Ercolini, A. M., & Miller, S. D. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03834.x · Cited by 413
Horai, R., Zárate-Bladés, C. R., Dillenburg-Pilla, P., Chen, J., Kielczewski, J. L., Silver, P. B., Jittayasothorn, Y., Chan, C.-C., Yamane, H., Honda, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.014 · Cited by 402
Understanding uveitis: The impact of research on visual outcomes
de Smet, M. D., Taylor, S. R. J., Bodaghi, B., Miserocchi, E., Murray, P. I., Pleyer, U., Zierhut, M., Barisani-Asenbauer, T., LeHoang, P., & Lightman, S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.06.005 · Cited by 340
Self-citationKempen, J. H., Altaweel, M. M., Holbrook, J. T., Jabs, D. A., Louis, T. A., Sugar, E. A., & Thorne, J. E. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.07.027 · Cited by 334
Mycophenolate Mofetil Therapy for Inflammatory Eye Disease
Thorne, J. E., Jabs, D. A., Qazi, F. A., Nguyen, Q. D., Kempen, J. H., & Dunn, J. P. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.02.020 · Cited by 219
Metadata
- Authors
- Durrani, O. M., Meads, C. A., & Murray, P. I.
- Venue
- Ophthalmologica
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 218
- Issue
- 4
- Pages
- 223-236
- ISSN
- 0030-3755 (ISSN-L)
- 1423-0267
- OpenAlex
- W2059141867
- Cited by
- 304
- References
- 87
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.